Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorDana-Farber Cancer Institute
About this trial
This study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast cancer in Rwanda. The intervention includes educational, behavioral, and reminder components, and will be assessed for feasibility and impact on medication adherence.
Eligibility criteria
Qualifiers
Female patients
Age 18 or older
Pathologic confirmation of ER-positive breast cancer
Clinical or radiographic confirmation of disease localized to the breast and regional lymph nodes
Disqualifiers
Unwilling/Unable to participate
Unable to comprehend study languages (English or Kinyarwanda)
Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Trial design
Treatments tested in this trial
- Educational video
- Symptom monitoring card
- Text reminders
Treatment groups
224 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov